{"id":{"repo_id":"msu","oai_identifier":"oai:d.lib.msu.edu:etd_52909"},"canonical_url":"https://search.ndltd.org/etd/msu/oai:d.lib.msu.edu:etd_52909","repository":{"repo_id":"msu","name":"Michigan State University","base_url":"https://d.lib.msu.edu/oai"},"display":{"title":"THE COOPERATION OF MUTANT IL7R AND RASGRP1 IN THYMOCYTE MATURATION AND T CELL LEUKEMOGENESIS","abstract":"Thesis (Ph.D.)--Michigan State University. Comparative Medicine and Integrative Biology - Doctor of Philosophy, 2025","abstract_html":"Thesis (Ph.D.)--Michigan State University. Comparative Medicine and Integrative Biology - Doctor of Philosophy, 2025","abstract_has_math":false,"creators":["Hsu, Tu Chun (Steven)"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["Meek, Katheryn","Harrington, Bonnie","Bernard, Jamie","Simpson, Robert M","Durum, Scott K"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2026,"date_issued":"2026","date_published":"2026","updated_at":"2026-11-18T18:59:31Z","subjects":["Pathology","Oncology","Veterinary science","Veterinary medicine"],"languages":["eng"],"rights":["In Copyright"],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:52909","local:Hsu_grad.msu_0128D_21906"],"render_values":[{"text":"etd:52909","href":null,"code":true},{"text":"local:Hsu_grad.msu_0128D_21906","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/doi:10.25335/6bq0-bf77","outbound_label":"DOI","outbound_source":"dc:identifier","record_url":"https://doi.org/doi:10.25335/6bq0-bf77","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://d.lib.msu.edu/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Ad.lib.msu.edu%3Aetd_52909","prefix":"oai_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Meek, Katheryn","Harrington, Bonnie","Bernard, Jamie","Simpson, Robert M","Durum, Scott K"]},{"key":"dc:creator","label":"Author","values":["Hsu, Tu Chun (Steven)"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2026"]},{"key":"dc:relation","label":"Dc Relation","values":["Electronic Theses & Dissertations"]},{"key":"dc:type","label":"Dc Type","values":["text","Electronic dissertations"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Pathology","Oncology","Veterinary science","Veterinary medicine"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["In Copyright"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:52909","local:Hsu_grad.msu_0128D_21906","https://doi.org/doi:10.25335/6bq0-bf77"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Thesis (Ph.D.)--Michigan State University. Comparative Medicine and Integrative Biology - Doctor of Philosophy, 2025","Acute lymphoblastic leukemia is the most common cancer in children. While the current therapy yields a 5-year survival of approximately 90%, there are numerous deleterious long-term effects: secondary malignancy, developmental alterations, and multisystemic toxicities. The development of targeted therapies, underpinned by a fundamental understanding of the molecular mechanisms of leukemogenesis, offers an intriguing path forward to reduce said effects. Approximately 10% and 50% of T-ALLs express mutant interleukin-7 receptor (mutIL7R) and RasGRP1, respectively. It was unknown whether the combination of these two oncogenes was sufficient for leukemogenesis. To address this knowledge gap, this dissertation combined the OP9-DL4 thymocyte co-culture system and retroviral transduction of mutIL7R and RasGRP1 to establish this combination of oncogenes as a novel sufficient pair for leukemogenesis. The resultant leukemia recapitulated various histopathologic features of natural disease. Further functional and transcriptional analyses of the leukemia revealed hyperactivation of the MAPK pathway, and not PI3K-AKT or JAK-STAT5 pathways. The mutIL7R+RasGRP1 leukemia also exhibited features of cancer, such as partial maturation arrest and metabolic dysfunction. The subtype-defining transcriptional factors currently used to classify T-ALLs were not significantly altered in the mutIL7R+RasGRP1 leukemia. While the mutIL7R and RasGRP1 are known to activate JAK and Ras, the inhibition of JAK1/2 (ruxolitinib) yielded a therapeutic effect, not MEK (trametinib). This dissertation underscored the central role of MAPK pathway activation in the leukemogenesis of a RasGRP1-overexpressing T-ALL model, the susceptibility of the leukemia to a JAK inhibitor, and the dispensability of MEK in leukemia progression.","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf","1 online resource (255 p.) : ill."]},{"key":"dc:title","label":"Title","values":["THE COOPERATION OF MUTANT IL7R AND RASGRP1 IN THYMOCYTE MATURATION AND T CELL LEUKEMOGENESIS"]}]}],"canonical_facts":{"dc:contributor":["Meek, Katheryn","Harrington, Bonnie","Bernard, Jamie","Simpson, Robert M","Durum, Scott K"],"dc:creator":["Hsu, Tu Chun (Steven)"],"dc:date":["2026"],"dc:description":["Thesis (Ph.D.)--Michigan State University. Comparative Medicine and Integrative Biology - Doctor of Philosophy, 2025","Acute lymphoblastic leukemia is the most common cancer in children. While the current therapy yields a 5-year survival of approximately 90%, there are numerous deleterious long-term effects: secondary malignancy, developmental alterations, and multisystemic toxicities. The development of targeted therapies, underpinned by a fundamental understanding of the molecular mechanisms of leukemogenesis, offers an intriguing path forward to reduce said effects. Approximately 10% and 50% of T-ALLs express mutant interleukin-7 receptor (mutIL7R) and RasGRP1, respectively. It was unknown whether the combination of these two oncogenes was sufficient for leukemogenesis. To address this knowledge gap, this dissertation combined the OP9-DL4 thymocyte co-culture system and retroviral transduction of mutIL7R and RasGRP1 to establish this combination of oncogenes as a novel sufficient pair for leukemogenesis. The resultant leukemia recapitulated various histopathologic features of natural disease. Further functional and transcriptional analyses of the leukemia revealed hyperactivation of the MAPK pathway, and not PI3K-AKT or JAK-STAT5 pathways. The mutIL7R+RasGRP1 leukemia also exhibited features of cancer, such as partial maturation arrest and metabolic dysfunction. The subtype-defining transcriptional factors currently used to classify T-ALLs were not significantly altered in the mutIL7R+RasGRP1 leukemia. While the mutIL7R and RasGRP1 are known to activate JAK and Ras, the inhibition of JAK1/2 (ruxolitinib) yielded a therapeutic effect, not MEK (trametinib). This dissertation underscored the central role of MAPK pathway activation in the leukemogenesis of a RasGRP1-overexpressing T-ALL model, the susceptibility of the leukemia to a JAK inhibitor, and the dispensability of MEK in leukemia progression.","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."],"dc:format":["application/pdf","1 online resource (255 p.) : ill."],"dc:identifier":["etd:52909","local:Hsu_grad.msu_0128D_21906","https://doi.org/doi:10.25335/6bq0-bf77"],"dc:language":["eng"],"dc:relation":["Electronic Theses & Dissertations"],"dc:rights":["In Copyright"],"dc:subject":["Pathology","Oncology","Veterinary science","Veterinary medicine"],"dc:title":["THE COOPERATION OF MUTANT IL7R AND RASGRP1 IN THYMOCYTE MATURATION AND T CELL LEUKEMOGENESIS"],"dc:type":["text","Electronic dissertations"]},"updated_at":"2026-11-18T18:59:31Z"}